HIG BioHealth Partners (HIG), the dedicated healthcare investment affiliate of private equity firm HIG Capital, has sold NeuWave Medical (NeuWave) to Ethicon, a medical device company of the Johnson & Johnson family of companies.
NeuWave is a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems. Their products are currently used by physicians in leading cancer centers throughout North America. Financial terms of the transaction were not disclosed.
Michael Wasserman, PhD, an HIG Managing Director and NeuWave board member, says: “Together with NeuWave’s talented management team, we successfully grew the company into a market leader in interventional oncology, developing and commercialising a suite of innovative products with significant benefits to patients, physicians and healthcare providers.
“Our investment in NeuWave was highly representative of HIG’s medical device investment strategy and continues to demonstrate our ability to generate outstanding financial returns for our investors.”
